Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RANBP2-like and GRIP domain-containing protein 5 is a protein encoded by the RGPD5 gene on human chromosome 2. It is highly homologous to RANBP2, a major protein of the nuclear pore complex. This protein contains Ran-binding and GRIP domains, suggesting it may be involved in protein trafficking around the nuclear envelope and in protein-protein interactions similar to its paralog RANBP2. While associated disease links include nephronophthisis and autism spectrum disorder, RGPD5 itself is not a recognized therapeutic target and is mainly studied for its basic cellular function or as a fusion partner in cancer genomics.
Not applicable. No known drugs target this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RANBP2-like and GRIP domain-containing protein 5 (RGPD5).